This content is machine translated European Diabetes Congress in Stockholm First antidiabetic drug with proven reduction in cardiovascular risk Some 15,600 people from 134 countries attended the 51st European Diabetes Conference in Stockholm (Annual Meeting of the European Association for the Study of Diabetes). The results of the EMPA-REG…
